Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-02-25 @ 9:41 PM
Study NCT ID:
NCT02927366
Status:
TERMINATED
Last Update Posted:
2021-01-05
First Post:
2016-10-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pulmonary Arterial Hypertension | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Pulmonary hypertension (PH), | View |
| None | Increase blood pressure in the pulmonary artery | View |
| None | Increased blood pressure in the pulmonary vein | View |
| None | Increased blood pressure in the lung vasculature | View |
| None | Shortness of breath | View |
| None | Dizziness | View |
| None | Fainting | View |
| None | Leg swelling | View |
| None | Cough | View |
| None | QCC374 | View |